Epicore Biosystems has secured an additional $6 million in funding, bringing its total Series B raise to $32 million. The company aims to expand its sweat-sensing wearables into new industrial markets in Australia, the Middle East, and Asia. The funding will also support the development of real-time analytics for personalized hydration guidance and the validation of biomarkers related to kidney health and stress.